-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on CVS Health, Raises Price Target to $92

Benzinga·12/10/2025 12:47:07
Listen to the news
Baird analyst Michael Ha maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $82 to $92.